Literature DB >> 11807841

Paraventricular nucleus of the human hypothalamus in primary hypertension: activation of corticotropin-releasing hormone neurons.

Valeri D Goncharuk1, Joop Van Heerikhuize, Dick F Swaab, Ruud M Buijs.   

Abstract

By using quantitative immunohistochemical and in situ hybridization techniques, we studied corticotropin-releasing hormone (CRH) -producing neurons of the hypothalamic paraventricular nucleus (PVN) in patients who suffered from primary hypertension and died due to acute cardiac failure. The control group consisted of individuals who had normal blood pressure and died of acute heart failure due to mechanical trauma. Both magno- and parvocellular populations of CRH neurons appeared to be more numerous in the PVN of hypertensive patients. Quantitative analysis showed approximately a twofold increase in the total number of CRH neurons and a more than fivefold increase in the amount of CRH mRNA in the hypertensive PVN compared with the control. It is suggested that synthesis of CRH in hypertensive PVN is enhanced. Increased activity of CRH-producing neurons in the PVN of hypertensive patients is proposed not only to entail hyperactivity of the hypothalamo-pituitary-adrenal axis, but also of the sympathetic nervous system and, thus, to be involved in the pathogenesis of hypertension. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807841     DOI: 10.1002/cne.10124

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  18 in total

Review 1.  Paraventricular nucleus, stress response, and cardiovascular disease.

Authors:  Eduardo E Benarroch
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

2.  Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels.

Authors:  William R Lovallo; Thomas L Whitsett; Mustafa al'Absi; Bong Hee Sung; Andrea S Vincent; Michael F Wilson
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

Review 3.  Circadian disruption and SCN control of energy metabolism.

Authors:  Andries Kalsbeek; Frank A Scheer; Stephanie Perreau-Lenz; Susanne E La Fleur; Chun-Xia Yi; Eric Fliers; Ruud M Buijs
Journal:  FEBS Lett       Date:  2011-03-21       Impact factor: 4.124

Review 4.  The impact of the circadian timing system on cardiovascular and metabolic function.

Authors:  Christopher J Morris; Jessica N Yang; Frank A J L Scheer
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

5.  Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase.

Authors:  Albert Alé; Yalin Zhang; Cheng Han; Dongsheng Cai
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-11-15       Impact factor: 4.310

Review 6.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

7.  Sex-specific impact of maternal-fetal risk factors on depression and cardiovascular risk 40 years later.

Authors:  J M Goldstein; S Cherkerzian; S L Buka; G Fitzmaurice; M Hornig; M Gillman; S O'Toole; R P Sloan
Journal:  J Dev Orig Health Dis       Date:  2011-12       Impact factor: 2.401

8.  Sex differences in NMDA GluN1 plasticity in rostral ventrolateral medulla neurons containing corticotropin-releasing factor type 1 receptor following slow-pressor angiotensin II hypertension.

Authors:  T A Van Kempen; M Dodos; C Woods; J Marques-Lopes; N J Justice; C Iadecola; V M Pickel; M J Glass; T A Milner
Journal:  Neuroscience       Date:  2015-08-22       Impact factor: 3.590

Review 9.  Do low levels of stress reactivity signal poor states of health?

Authors:  William R Lovallo
Journal:  Biol Psychol       Date:  2010-01-14       Impact factor: 3.251

Review 10.  Sex differences in major depression and comorbidity of cardiometabolic disorders: impact of prenatal stress and immune exposures.

Authors:  Jill M Goldstein; Taben Hale; Simmie L Foster; Stuart A Tobet; Robert J Handa
Journal:  Neuropsychopharmacology       Date:  2018-07-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.